Deprecated: Return type of DrupalCacheArray::offsetExists($offset) should either be compatible with ArrayAccess::offsetExists(mixed $offset): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/rprlib/prod72/www/includes/bootstrap.inc on line 362
Deprecated: Return type of DrupalCacheArray::offsetGet($offset) should either be compatible with ArrayAccess::offsetGet(mixed $offset): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/rprlib/prod72/www/includes/bootstrap.inc on line 369
Deprecated: Return type of DrupalCacheArray::offsetSet($offset, $value) should either be compatible with ArrayAccess::offsetSet(mixed $offset, mixed $value): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/rprlib/prod72/www/includes/bootstrap.inc on line 381
Deprecated: Return type of DrupalCacheArray::offsetUnset($offset) should either be compatible with ArrayAccess::offsetUnset(mixed $offset): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/rprlib/prod72/www/includes/bootstrap.inc on line 388 Chlorthalidone
https://www.rpr.lib.ok.us/taxonomy/term/9013/all
enChlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events
https://www.rpr.lib.ok.us/resource/chlorthalidone-vs-hydrochlorothiazide-hypertension%E2%80%93cardiovascular-events
<div class="field field-name-field-artifact-uploaded-date field-type-datetime field-label-inline clearfix">
<div class="field-label">Date Added: </div>
<div class="field-items">
<div class="field-item even"><span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2022-12-19T00:00:00-06:00">December 19, 2022</span></div>
</div>
</div>
<div class="field field-name-field-artifact-journal field-type-text field-label-inline clearfix">
<div class="field-label">Journal/Publication: </div>
<div class="field-items">
<div class="field-item even">New England Journal of Medicine</div>
</div>
</div>
<div class="field field-name-field-artifact-publisher field-type-text field-label-inline clearfix">
<div class="field-label">Publisher: </div>
<div class="field-items">
<div class="field-item even">Massachusetts Medical Society</div>
</div>
</div>
<div class="field field-name-field-artifact-published-date field-type-datetime field-label-inline clearfix">
<div class="field-label">Publication Date: </div>
<div class="field-items">
<div class="field-item even"><span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2022-12-14T00:00:00-06:00">December 14, 2022</span></div>
</div>
</div>
<div class="field field-name-field-artifact-url field-type-link-field field-label-inline clearfix">
<div class="field-label">URL: </div>
<div class="field-items">
<div class="field-item even"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2212270?query=TOC&cid=NEJM%20eToc%2C%20December%2015%2C%202022%20DM1776064_NEJM_Non_Subscriber&bid=1312554587" target="_blank">Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events</a></div>
</div>
</div>
<div class="field field-name-field-artifact-type field-type-taxonomy-term-reference field-label-inline clearfix">
<div class="field-label">Type: </div>
<div class="field-items">
<div class="field-item even">Clinical Research Results</div>
</div>
</div>
<div class="field field-name-field-artifact-format field-type-taxonomy-term-reference field-label-inline clearfix">
<div class="field-label">Format: </div>
<div class="field-items">
<div class="field-item even">Article</div>
</div>
</div>
<div class="field field-name-field-artifact-doi-1 field-type-text field-label-inline clearfix">
<div class="field-label">DOI (1): </div>
<div class="field-items">
<div class="field-item even">10.1056/NEJMoa2212270</div>
</div>
</div>
<div class="field field-name-field-artifact-keywords field-type-taxonomy-term-reference field-label-above">
<div class="field-label">Keywords </div>
<div class="field-items">
<div class="field-item even"><a href="/tags/hypertension" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">hypertension</a></div>
<div class="field-item odd"><a href="/tags/cardiovascular-events" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">cardiovascular events</a></div>
<div class="field-item even"><a href="/tags/heart-failure" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">heart failure</a></div>
<div class="field-item odd"><a href="/tags/veterans" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">veterans</a></div>
<div class="field-item even"><a href="/tags/infarction" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">infarction</a></div>
</div>
</div>
<div class="field field-name-field-artifact-pmid-1 field-type-text field-label-inline clearfix">
<div class="field-label">PMID (1): </div>
<div class="field-items">
<div class="field-item even">36516076</div>
</div>
</div>
<div class="field field-name-field-artifact-mesh field-type-taxonomy-term-reference field-label-above">
<div class="field-label">MeSH </div>
<div class="field-items">
<div class="field-item even"><a href="/mesh/hydrochlorothiazide" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Hydrochlorothiazide</a></div>
<div class="field-item odd"><a href="/mesh/sodium-chloride-symporter-inhibitors" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Sodium Chloride Symporter Inhibitors</a></div>
<div class="field-item even"><a href="/mesh/hypokalemia" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Hypokalemia</a></div>
<div class="field-item odd"><a href="/mesh/angina-unstable" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Angina, Unstable</a></div>
<div class="field-item even"><a href="/mesh/chlorthalidone" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Chlorthalidone</a></div>
</div>
</div>
<div class="field field-name-field-artifact-editor-note field-type-text-long field-label-hidden">
<div class="field-items">
<div class="field-item even"><p>HCYZ seems to be as effective as chlorthalidone for reducing the risk of major CV events. James W. Mold, MD, MPH</p>
</div>
</div>
</div>
<div class="field field-name-field-artifact-text-availability field-type-list-text field-label-hidden">
<div class="field-items">
<div class="field-item even">Free full text</div>
</div>
</div>
<div class="field field-name-field-artifact-document-content field-type-entityreference field-label-hidden">
<div class="field-items">
<div class="field-item even"><div class="view view-artifact-docs view-id-artifact_docs view-display-id-block view-dom-id-4e2d5dc2d317d49d44054d61216478fa">
<div class="view-content">
<div class="views-row views-row-1 views-row-odd views-row-first views-row-last">
<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2212270?query=TOC&cid=NEJM%20eToc%2C%20December%2015%2C%202022%20DM1776064_NEJM_Non_Subscriber&bid=1312554587" class="btn btn-primary" target="_blank">View</a> </div>
</div>
</div></div>
</div>
</div>
<div class="field field-name-body field-type-text-with-summary field-label-hidden">
<div class="field-items">
<div class="field-item even" property="content:encoded"><p>Background: Whether chlorthalidone is superior to hydrochlorothiazide for preventing major adverse cardiovascular events in patients with hypertension is unclear.</p>
<p>Methods: In a pragmatic trial, we randomly assigned adults 65 years of age or older who were patients in the Department of Veterans Affairs health system and had been receiving hydrochlorothiazide at a daily dose of 25 or 50 mg to continue therapy with hydrochlorothiazide or to switch to chlorthalidone at a daily dose of 12.5 or 25 mg. The primary outcome was a composite of nonfatal myocardial infarction, stroke, heart failure resulting in hospitalization, urgent coronary revascularization for unstable angina, and non-cancer-related death. Safety was also assessed.</p>
<p>Results: A total of 13,523 patients underwent randomization. The mean age was 72 years. At baseline, hydrochlorothiazide at a dose of 25 mg per day had been prescribed in 12,781 patients (94.5%). The mean baseline systolic blood pressure in each group was 139 mm Hg. At a median follow-up of 2.4 years, there was little difference in the occurrence of primary-outcome events between the chlorthalidone group (702 patients [10.4%]) and the hydrochlorothiazide group (675 patients [10.0%]) (hazard ratio, 1.04; 95% confidence interval, 0.94 to 1.16; P = 0.45). There were no between-group differences in the occurrence of any of the components of the primary outcome. The incidence of hypokalemia was higher in the chlorthalidone group than in the hydrochlorothiazide group (6.0% vs. 4.4%, P<0.001).</p>
<p>Conclusions: In this large pragmatic trial of thiazide diuretics at doses commonly used in clinical practice, patients who received chlorthalidone did not have a lower occurrence of major cardiovascular outcome events or non-cancer-related deaths than patients who received hydrochlorothiazide. (Funded by the Veterans Affairs Cooperative Studies Program; ClinicalTrials.gov number, NCT02185417.).</p>
</div>
</div>
</div>
<div class="field field-name-field-resource-author field-type-taxonomy-term-reference field-label-inline clearfix">
<div class="field-label">Author/s: </div>
<div class="field-items">
<div class="field-item even">Ishani, A., Cushman, W. C., Leatherman, S. M., R. A., Woods, P., Glassman, P. A., Taylor, A. A., Hau, C., Klint, A., Huang, G. D., Brophy, M. T., Fiore, L. D., Ferguson, R. E., Diuretic Comparison Project Writing Group</div>
</div>
</div>
Mon, 19 Dec 2022 06:00:00 +0000Aubrey Delammermore1947 at https://www.rpr.lib.ok.us